Please assess the completion status of the following clinical trial:

Trial Title: Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients age 18-55~* Signs or symptoms consistent with sexually transmitted infection~* Medical provider willing to consider the result of the rapid turnaround test in decision to treat for gonorrhea/chlamydia~* Must have a urine specimen obtained and a pelvic exam performed as part of the anticipated standard of care evaluation~* Provides informed consent~Exclusion Criteria:~* Signs of systemic infection~* Patient in whom the provider is unwilling to consider the result of the rapid turnaround test~* Patient who reports being treated for either gonorrhea or chlamydia in the preceding 3 months~* Patients undergoing evaluation for sexual assault~* Patients that are known to be pregnant or express concern that they may be pregnant~* Incarcerated patients~* Students/Employees of the facility~* Presence of any other condition(s) that the investigator feels makes the patient unsuitable for study inclusion.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Rapid Turnaround Test (Type: EXPERIMENTAL): Patients randomized to this arm will be tested for a sexually transmitted infection (STI) with both the rapid nucleic acid amplification test (NAAT) as well as the conventional polymerase chain reaction (PCR) test. The results from the rapid turnaround test will guide providers on treatment decisions for a possible STI. The results from the PCR test will be used to verify the results of the rapid turnaround test.
- Usual Care (Type: ACTIVE_COMPARATOR): Patients randomized to this arm will be tested for a sexually transmitted infection (STI) using the conventional PCR test. The results from the PCR test normally take approximately 48-72 hours and these patients will likely receive treatment based on the decision of the clinical provider. The results from the PCR test will be used to verify the decision of the clinical provider to treat or withhold treatment for a possible STI.

Based on this trial design, predict the completion outcome and termination type (if applicable).